PostEra

PostEra is pioneering a new paradigm in biopharmaceutical development for the 21st century. By leveraging cutting-edge advancements in machine learning, they are significantly accelerating the medicinal chemistry process, with the ultimate goal of delivering more effective treatments to patients. PostEra pursues this mission through strategic partnerships with established biopharmaceutical companies, while simultaneously developing its own internal pipeline of innovative therapies. Having secured $26 million in funding from leading investors and established over $1 billion in AI-driven partnerships, including multi-year agreements with industry giants like Amgen, Pfizer, and the NIH, PostEra is rapidly expanding its reach. Furthermore, PostEra spearheaded and continues to lead COVID Moonshot, the world's largest open-science drug discovery initiative, demonstrating a commitment to collaborative innovation and global health.